Clinical Trials: A clinical trial involves research participants. It follows a pre-defined plan or protocol to evaluate the effects of a medical or behavioral intervention on health outcomes. Clinical trials are done to determine whether new drugs or treatments are safe and effective. By taking part in clinical trials, participants not only play a more active role in their own health care, but they also can access experimental treatments and help others by contributing to medical research.
-
FEB 22, 2023 | 5:30 AM
C.E. CREDITS
Ninety percent of therapeutic agents reaching clinical trial fail to reach entry to market, with safety concerns being a major cause for failures in phase I and II clinical trials. Drug-indu...
FEB 21, 2023 | 10:00 AM
C.E. CREDITS
Date: February 21, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The use of algorithms that alter patient medical care based on race has fallen under increasing criticism, as race-bas...
NOV 16, 2022 | 7:00 PM
C.E. CREDITS
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
Date: November 16, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) No more estimating. No more ranges. No more uncertainty. While PDX tumor models are crucial for gaining predictive ins...
NOV 09, 2022 | 8:00 AM
C.E. CREDITS
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
Date: November 08, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) While flow cytometry shines by its flexibility, it requires a high level of expertise in antibody panel development,...
Date: October 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the pa...
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...
The diagnosis of venous thromboembolism (VTE) is challenging during pregnancy. Pregnant women often present with symptoms compatible with VTE. The use of conventional diagnostic algorithms is...
Date: September 27, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Alzheimer’s disease is the most common cause of dementia and the seventh leading cause of death in the United...
Getting It Right: Preanalytical Impact on Coagulation Results Using a Case Study Approach According to published literature, up to 65% of errors occur in the preanalytical phase of laborator...
Date: August 16, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this session, researchers, clinicians, and program implementers from four countries will address the disruption in co...
Date: June 21, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Human-induced pluripotent stem cell (iPSC) technology allows for “clinical trials in-a-dish” because patient...
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
Date: June 02, 2022 Time: 8:30am (PST), 10:30am (CST), 11:30am (EST) Cardiac biomarkers like high-sensitivity Troponin I might play a major role in the prevention of cardiovascular diseases....
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...
Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. The ability to swiftly develop novel therapies often depends...
The need for next-generation, broadly protective coronavirus vaccines is underscored by the accelerated pace at which human coronaviruses have been emerging, the evolution of the current pan...
According to published literature, up to 65% of errors occur in the preanalytical phase of laboratory testing, and coagulation assays are particularly sensitive to preanalytical issues......